Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
iXensor CoROCO:6734 -2.64%55 EBITDA Margin % is -120.59% as of Dec. 2025. GuruFocus rates ROCO:6734 with a GF Score™ of 55/100 and a GF Value™ of NT$5.78 (Modestly Overvalued). The stock has 5 warning signs investors should review. Among 816 Medical Devices & Instruments companies, iXensor Co ranks worse than 86.27% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. iXensor Co's EBITDA for the
six
months ended in Dec. 2025 was NT$-17.30 Mil. iXensor Co's Revenue for the
six
months ended in Dec. 2025 was NT$14.34 Mil. Therefore, iXensor Co's EBITDA margin for the quarter that ended in Dec. 2025 was -120.59%.
iXensor Co (ROCO:6734) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
iXensor Co EBITDA Margin % Related Terms
iXensor Co EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for iXensor Co's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:6734 vs ABT, SYK, MDT: EBITDA Margin % Comparison
For the Medical Devices subindustry, iXensor Co's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
iXensor Co EBITDA Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, iXensor Co's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where iXensor Co's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
iXensor Co (ROCO:6734) has a EBITDA Margin % of -120.59% as of Dec. 2025. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on iXensor Co and its competitors. According to the industry distribution chart, iXensor Co ranks #704 out of 816 companies in the Medical Devices & Instruments industry, placing it in the top 86.3%.
Is iXensor Co's EBITDA Margin % too high?
iXensor Co's current EBITDA Margin % is -120.59%. Based on the distribution chart, iXensor Co ranks #704 out of 816 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, iXensor Co has a GF Score™ of 55/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does iXensor Co's EBITDA Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, iXensor Co ranks #704 out of 816 companies for EBITDA Margin %. This places iXensor Co in the lower half of its industry. The industry median EBITDA Margin % is 7.46. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Medical Devices & Instruments company?
The median EBITDA Margin % among Medical Devices & Instruments companies is 7.46, based on 816 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on iXensor Co and its competitors. For the Medical Devices & Instruments industry, the median EBITDA Margin % is 7.46 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. iXensor Co's current EBITDA Margin % is -120.59%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is iXensor Co stock overvalued right now?
Based on GuruFocus' analysis, iXensor Co (ROCO:6734) is currently considered Modestly Overvalued. The stock's GF Value™ is NT$5.78, compared to a current price of NT$6.65 — trading 15.1% above its estimated fair value. The current EBITDA Margin % is -120.59%. iXensor Co's overall GF Score™ is 55/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For iXensor Co (ROCO:6734), the current EBITDA Margin % is -120.59% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is iXensor Co (ROCO:6734) Overvalued in 2026?
Based on GuruFocus' analysis, iXensor Co stock appears to be overvalued.
The current stock price of NT$6.65 is trading 15.1% above its estimated GF Value™ of NT$5.78.
GuruFocus considers iXensor Co to be Modestly Overvalued.
Key valuation signals for ROCO:6734:
EBITDA Margin %: -120.59%
GF Value™: NT$5.78 vs. price of NT$6.65 (15.1% above fair value)
No single metric tells the full story. See the ROCO:6734 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
iXensor Co Ltd is a Taiwan based company involved in research and development, manufacturing and sales of medical equipment. Its PixoTest technology utilizes the lighting and image sensing module of the smartphone or mobile device to detect the color change reaction on the biochemical test strip. This enables the users to monitor their conditions of diabetes, cardiovascular diseases, women health problems, or infectious diseases.
55GF Score
Get the complete analysis for ROCO:6734
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:6734 has been successfully added to your 
